WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
Prepared by the Crisis Manual Subcommittee of the Marketing & Advertising Committee, this manual includes proper crisis preparedness and management processes that can help protect a brand’s reputation and market share. This guide includes industry specific tools for crisis resistance, responsiveness, and resilience. Read more
In this report prepared by NCIA’s Policy Council, we explore recommendations for cannabis testing policies including requirements for proficiency, contaminants, potency and active ingredients, as well as records retention and laboratory accreditation. Read more
Canopy Growth (TSX:WEED / NYSE:CGC) is the world’s largest legal marijuana company and it just made another big move to further cement its leadership position. Yesterday Canopy announced it was going to acquire Hiku Brands (TSXV:HIKU / US OTC:DJACF) for C$1.91 a share. The total deal is valued at right around US$200 million and... Read more
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
WINNIPEG, March 27, 2018 /CNW/ – DELTA 9 CANNABIS INC. (TSXV: NINE) (“Delta 9” or the “Company”) is pleased to announce that the Company has signed a non-binding letter of intent (the “LOI”) with CanPharma GMBH (“CanPharma”) and Global Group Kalapa S.L. (“Kalapa”) for the exportation of medical cannabis to Germany. Manitoba-based Delta... Read more
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
